1. Translating the epitranscriptome
   Thomas Philipp Hoernes et al, 2017, WIREs RNA CrossRef
2. New approaches to the treatment of orphan genetic disorders: Mitigating molecular pathologies using chemicals
   RENATA V. VELHO et al, 2015, An. Acad. Bras. Ciênc. CrossRef
3. A Protein Biosynthesis Machinery Strategy for Identifying P53PTC -Rescuing Compounds as Synergic Anti-Tumor Drugs
   Jingjing Zhou et al, 2018, ChemistrySelect CrossRef
4. Safety, Tolerability, and Pharmacokinetics of Single Ascending Doses of ELX-02, a Potential Treatment for Genetic Disorders Caused by Nonsense Mutations, in Healthy Volunteers
   Andi Leubitz et al, 2019, Clinical Pharmacology in Drug Development CrossRef
5. Therapeutic developments for Duchenne muscular dystrophy
   Ingrid E. C. Verhaart et al, 2019, Nat Rev Neurol CrossRef
6. Strategies against Nonsense: Oxadiazoles as Translational Readthrough-Inducing Drugs (TRIDs)
   Ambra Campofelice et al, 2019, IJMS CrossRef
7. Enhancement of premature stop codon readthrough in the CFTR gene by Ataluren (PTC124) derivatives
   Ivana Pibiri et al, 2015, European Journal of Medicinal Chemistry CrossRef
8. Gene-targeting pharmaceuticals for single-gene disorders
   Arthur L. Beaudet et al, 2016, Hum. Mol. Genet. CrossRef
9. Mendelian Disorders of Cornification Caused by Defects in Intracellular Calcium Pumps: Mutation Update and Database for Variants in ATP2A2 and ATP2C1 Associated with Darier Disease and Hailey-Hailey Disease
   Ruud G.L. Nellen et al, 2017, Human Mutation CrossRef
10. null
    Guillaume F. Chanfreau, 2017 CrossRef
11. A Direct Approach to Decoration of Bioactive Compounds via C–H Amination Reaction
    Guodong Ju et al, 2019, Org. Lett. CrossRef
12. Frontotemporal dementia non-sense mutation of progranulin rescued by aminoglycosides
    Lisha Kuang et al, 2020 CrossRef
13. Suppression of Nonsense Mutations by New Emerging Technologies
    Pedro Morais et al, 2020, IJMS CrossRef
14. Pseudouridine-mediated stop codon readthrough in S. cerevisiae is sequence context–independent
    Hironori Adachi et al, 2020, RNA CrossRef
15. MMADHC premature termination codons in the pathogenesis of cobalamin D disorder: Potential of translational readthrough reconstitution.
    Rafael Pulido, 0 CrossRef
16. Therapeutic promise of engineered nonsense suppressor tRNAs
    Joseph J. Porter et al, 2021, WIREs RNA CrossRef
17. Restoration of dystrophin expression in mice by suppressing a nonsense mutation through the incorporation of unnatural amino acids
    Ningning Shi et al, 2021, Nat Biomed Eng CrossRef
18. Ataluren—Promising Therapeutic Premature Termination Codon Readthrough Frontrunner
    Sylwia Michorowska, 2021, Pharmaceuticals CrossRef
19. A systematic dissection of determinants and consequences of snoRNA-guided pseudouridylation of human mRNA
    Ronit Nir et al, 2022 CrossRef
20. Premature termination codon: a tunable protein translation approach
    Xiyao Cheng et al, 2022, BioTechniques CrossRef
21. Resolving Ultrafast Photoinitiated Dynamics of the Hachimoji 5‐aza‐7‐deazaguanine Nucleobase: Impact of Synthetically Expanding the Genetic Alphabet 1
    Sarah E. Krul et al, 2022, Photochem & Photobiology CrossRef
22. Nonsense codons suppression. An acute toxicity study of three optimized TRIDs in murine model, safety and tolerability evaluation
    Federica Corrao et al, 2022, Biomedicine & Pharmacotherapy CrossRef
23. Ovarian cancer onset across differentBRCAmutation types: a view to a more tailored approach forBRCAmutated patients
    Claudia Marchetti et al, 2022, Int J Gynecol Cancer CrossRef
24. Mini-dCas13X–mediated RNA editing restores dystrophin expression in a humanized mouse model of Duchenne muscular dystrophy
    Guoling Li et al, 2023 CrossRef
25. Targeted pseudouridylation: An approach for suppressing nonsense mutations in disease genes
    Hironori Adachi et al, 2023, Molecular Cell CrossRef
26. Targeted Pseudouridylation: A Novel Approach for Suppressing Nonsense Mutations in Disease Genes
    Hironori Adachi et al, 2021, SSRN Journal CrossRef
27. Advanced genetic therapies for the treatment of Rett syndrome: state of the art and future perspectives
    Michela Palmieri et al, 2023, Front. Neurosci. CrossRef
28. null
    Zhetao Zheng et al, 2023 CrossRef
29. Applications of genetic code expansion technology in eukaryotes
    Qiao-ru Guo et al, 2023 CrossRef
30. Special issue on nucleic acid photophysics
    Carlos E. Crespo‐Hernández, 2024, Photochem & Photobiology CrossRef